JP2005539062A5 - - Google Patents

Download PDF

Info

Publication number
JP2005539062A5
JP2005539062A5 JP2004536213A JP2004536213A JP2005539062A5 JP 2005539062 A5 JP2005539062 A5 JP 2005539062A5 JP 2004536213 A JP2004536213 A JP 2004536213A JP 2004536213 A JP2004536213 A JP 2004536213A JP 2005539062 A5 JP2005539062 A5 JP 2005539062A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
hydrogen
compound
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004536213A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005539062A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/028696 external-priority patent/WO2004024086A2/en
Publication of JP2005539062A publication Critical patent/JP2005539062A/ja
Publication of JP2005539062A5 publication Critical patent/JP2005539062A5/ja
Pending legal-status Critical Current

Links

JP2004536213A 2002-09-13 2003-09-11 化合物、組成物および方法 Pending JP2005539062A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41074302P 2002-09-13 2002-09-13
PCT/US2003/028696 WO2004024086A2 (en) 2002-09-13 2003-09-11 Compounds, compositions and methods

Publications (2)

Publication Number Publication Date
JP2005539062A JP2005539062A (ja) 2005-12-22
JP2005539062A5 true JP2005539062A5 (cg-RX-API-DMAC7.html) 2006-10-12

Family

ID=31994196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004536213A Pending JP2005539062A (ja) 2002-09-13 2003-09-11 化合物、組成物および方法

Country Status (5)

Country Link
US (1) US20080312310A1 (cg-RX-API-DMAC7.html)
EP (1) EP1554265A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005539062A (cg-RX-API-DMAC7.html)
AU (1) AU2003267169A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004024086A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4664597B2 (ja) 2002-04-17 2011-04-06 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
DE602005008953D1 (de) 2004-05-21 2008-09-25 Novartis Vaccines & Diagnostic Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
MXPA06014909A (es) 2004-06-18 2007-02-28 Chiron Corp Derivados de n-(1-(1-bencil -4-fenil-1h -imidazol -2-il)-2, 2-dimetilpropil) benzamida y compuestos relacionados como inhibidores de proteina de huso de cinesina (ksp) para el tratamiento del cancer.
CN101027309B (zh) 2004-08-18 2010-10-27 阿斯利康(瑞典)有限公司 所选择的稠合嘧啶酮的对映体和在治疗和预防癌症中的用途
EP1807399A2 (en) 2004-10-19 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Indole and benzimidazole derivatives
MX2009005071A (es) 2006-11-13 2009-05-25 Novartis Ag Compuestos de pirazol y triazol sustituidos como inhibidores de ksp.
GEP20125415B (en) 2007-01-05 2012-03-12 Novartis Ag Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
US8912244B2 (en) * 2012-03-09 2014-12-16 Protocol Environmental Solutions Inc. Non-film forming compositions and methods of protecting cured concrete and cementitious materials

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3177130D1 (de) * 1980-08-30 1990-01-11 Hoechst Ag Aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung.
US4434296A (en) * 1982-05-17 1984-02-28 The Upjohn Company Process for preparing intermediates for antiatherosclerotic compounds
US4482558A (en) * 1982-06-18 1984-11-13 Pfizer Inc. Antifungal amide and urea derivatives of (3-amino-2-aryl-2-hydroxyprop-1-yl)-1H-1,2,4-triazoles
JPS62201882A (ja) * 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
IN164232B (cg-RX-API-DMAC7.html) * 1986-04-11 1989-02-04 Hoechst India
IL85554A0 (en) * 1987-03-02 1988-08-31 Takeda Chemical Industries Ltd Chromone derivatives
JPH0753725B2 (ja) * 1987-10-08 1995-06-07 富山化学工業株式会社 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
USH1427H (en) * 1988-04-06 1995-04-04 Briet; Phillipe Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
US5304548A (en) * 1988-08-16 1994-04-19 The Upjohn Company Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
US5180717A (en) * 1988-08-16 1993-01-19 The Upjohn Company Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
US5703075A (en) * 1988-12-21 1997-12-30 Pharmacia & Upjohn Company Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
US5082849A (en) * 1989-07-13 1992-01-21 Huang Fu Chich Quinolinyl-benzopyran derivatives as antagonists of leukotriene D4
US4977162A (en) * 1989-07-13 1990-12-11 Rorer Pharmaceutical Corporation Quinolinyl-chromone derivatives and use for treatment of hypersensitive ailments
US5215989A (en) * 1989-12-08 1993-06-01 Merck & Co., Inc. Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
CA2087423A1 (en) * 1990-07-25 1992-01-26 Tatsuki Shiota Benzopyran derivative, process for producing the same and pharmaceutical composition containing the same
US5605896A (en) * 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
CA2184002A1 (en) * 1994-02-23 1995-08-31 Jeffrey M. Blaney Method and compositions for increasing the serum half-life of pharmacologically active agents
EP0764159B1 (en) * 1994-06-10 2000-08-09 Smithkline Beecham Plc C -4 amide substituted compounds and their use as therapeutic agents
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
US5602171A (en) * 1995-06-07 1997-02-11 Sugen Inc. Methods of inhibiting phosphatase activity and treatment of disorders associated therewith using naphthopyrones and derivatives thereof
US6087385A (en) * 1998-10-30 2000-07-11 University Of Mississippi Flavonoid derivatives
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
DE19858341A1 (de) * 1998-12-17 2000-06-21 Merck Patent Gmbh Chromanderivate
US6559160B1 (en) * 1999-08-27 2003-05-06 Chemocentryx, Inc. Compounds and methods for modulating cxcr3 function
GB9920912D0 (en) * 1999-09-03 1999-11-10 Indena Spa Novel derivatives of flavones,xanthones and coumarins
DE60017157T2 (de) * 1999-09-16 2005-12-22 Curis, Inc., Cambridge Vermittler von igel signalwegen, deren zusammenstellungen und verwendungen
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US6559145B2 (en) * 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6903121B1 (en) * 2000-08-17 2005-06-07 Allergan, Inc. Treatment of tumors with acetylenes disubstituted with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents
NZ526622A (en) * 2000-12-11 2006-07-28 Amgen Sf Llc CXCR3 antagonists
JP2003286301A (ja) * 2002-01-22 2003-10-10 Omron Corp 2段階硬化型樹脂組成物、微細賦形成形物およびその製造方法、ならびに精密機器
JP4664597B2 (ja) * 2002-04-17 2011-04-06 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
ATE423110T1 (de) * 2002-07-17 2009-03-15 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
AU2003249534A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc 6,6-fused heteroaryl derivatives as matrix metalloproteinase inhibitors
JP2007507539A (ja) * 2003-10-06 2007-03-29 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
WO2005040163A1 (en) * 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Heterocyclic compounds that block the effects of advanced glycation end products (age)

Similar Documents

Publication Publication Date Title
JP2006500394A5 (cg-RX-API-DMAC7.html)
RU2000117278A (ru) Производное 2-арил-8-оксодигидропурина, способ для его получения, содержащая его фармацевтическая композиция, и промежуточное соединение
JP2005538062A5 (cg-RX-API-DMAC7.html)
BR0308212A (pt) Composto, composição farmacêutica, e, uso de um composto
RU98115659A (ru) Сульфированные аминокислотные производные и содержащие их ингибиторы металлопротеиназ
EP2275107A3 (en) Combinations for the treatment of diseases involving cell proliferation
EP2251327A3 (en) Heterocyclic inhibitors of MEK and methods of use thereof
RU2004135554A (ru) Пиримидиноны, композиции на их основе и способы их использования
BR9916590A (pt) Derivado de pirimidina, processo para a preparação de um derivado de pirimidina, método para a produção de um efeito anti-câncer em um animal de sangue quente, uso do derivado de pirimidina, e, composição farmacêutica
JP2006508030A5 (cg-RX-API-DMAC7.html)
JPH11193282A5 (cg-RX-API-DMAC7.html)
BR0113496A (pt) Composto ou um sal farmaceuticamente aceitável ou ester hidrolisável in vivo deste, uso destes, método para produzir um efeito inibidor do ciclo celular (anti-proliferação celular) em um animal de sangue quente, e, composição farmacêutica
BR0109577A (pt) Composto, processo para preparar o mesmo, composição farmacêutica, uso de um composto, e, método para tratar cânceres em um animal de sangue quente
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
RU2007130802A (ru) Пуриновые производные в качестве агонистов рецептора а2а
CA2539738A1 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JP2006502219A5 (cg-RX-API-DMAC7.html)
JP2005533119A5 (cg-RX-API-DMAC7.html)
RU2005114491A (ru) Соединения, составы и способы их использования
RU2002130247A (ru) Производные оксадиазола, обладающие противоопухолевым действием
MY139676A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
AU2003279570A1 (en) Delivery agent, method of delivering a target substance to cells, method for producing delivery agent, composition for producing delivery agent, and kit for producing delivery agent
SE0203300D0 (sv) Novel Compounds
JP2006505541A5 (cg-RX-API-DMAC7.html)
JP2006514013A5 (cg-RX-API-DMAC7.html)